Anticancer Effects of ACT001 via NF-κB Suppression in Murine Triple-Negative Breast Cancer Cell Line 4T1
Yanyang Liu,* Li Wang,* Jiewei Liu, Xiaoxiao Xie, Haoyue Hu, Feng Luo Lung Cancer Center, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu 610041, Sichuan, People’s Republic of China*These authors contributed equally to this workCorre...
Main Authors: | Liu Y, Wang L, Liu J, Xie X, Hu H, Luo F |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-06-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/anticancer-effects-of-act001-via-nf-kappab-suppression-in-murine-tripl-peer-reviewed-article-CMAR |
Similar Items
-
ACT001 attenuates microglia-mediated neuroinflammation after traumatic brain injury via inhibiting AKT/NFκB/NLRP3 pathway
by: Lin Cai, et al.
Published: (2022-04-01) -
Administration of Parthenolide extract (ACT001) improved autophagy and attenuate inflammatory in Rats with ARDS
by: Qiang Fu, et al.
Published: (2022-12-01) -
Does the Dose of Standard Adjuvant Chemotherapy Affect the Triple-negative Breast Cancer Benefit from Extended Capecitabine Metronomic Therapy? An Exploratory Analysis of the SYSUCC-001 Trial
by: Chen Y, et al.
Published: (2024-04-01) -
KPT‐330 and Y219 exert a synergistic antitumor effect in triple‐negative breast cancer through inhibiting NF‐κB signaling
by: Tiantian Wen, et al.
Published: (2023-04-01) -
ACT001 Alleviates chronic kidney injury induced by a high-fat diet in mice through the GPR43/AMPK pathway
by: Yibing Zhou, et al.
Published: (2023-11-01)